KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $527,000 | -3.1% | 155,009 | +7.2% | 0.05% | -88.8% |
| Q2 2018 | $544,000 | -33.2% | 144,564 | -27.4% | 0.48% | -31.9% |
| Q1 2018 | $814,000 | -16.9% | 199,089 | -5.5% | 0.71% | -42.6% |
| Q4 2017 | $980,000 | -12.1% | 210,666 | +34.1% | 1.23% | +720.0% |
| Q3 2017 | $1,115,000 | -1.8% | 157,065 | 0.0% | 0.15% | -11.8% |
| Q2 2017 | $1,136,000 | +0.3% | 157,065 | -14.6% | 0.17% | -15.8% |
| Q1 2017 | $1,133,000 | +16.3% | 183,907 | +10.6% | 0.20% | -30.6% |
| Q4 2016 | $974,000 | +73.3% | 166,223 | +57.0% | 0.29% | +7.0% |
| Q3 2016 | $562,000 | -8.3% | 105,877 | +14.4% | 0.27% | -40.2% |
| Q2 2016 | $613,000 | -3.8% | 92,536 | -32.2% | 0.46% | -48.2% |
| Q1 2016 | $637,000 | -7.5% | 136,472 | 0.0% | 0.88% | -53.6% |
| Q4 2015 | $689,000 | – | 136,472 | – | 1.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 700,273 | $10,770,000 | 5.76% |
| HARVEY CAPITAL MANAGEMENT INC | 932,400 | $14,340,000 | 5.13% |
| Camber Capital Management LP | 3,000,000 | $46,140,000 | 3.02% |
| Baupost Group | 10,539,986 | $162,105,000 | 2.64% |
| SECTORAL ASSET MANAGEMENT INC | 3,741,656 | $57,547,000 | 2.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,884,409 | $59,742,000 | 2.40% |
| Knoll Capital Management, LLC | 200,000 | $3,076,000 | 1.37% |
| DAFNA Capital Management LLC | 92,400 | $1,421,000 | 1.35% |
| NORTHPOINTE CAPITAL LLC | 892,011 | $13,719,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 240,000 | $3,691,000 | 1.10% |